Endometrial cancer staging

	Endometrial cancer Microchapters
Home
Patient Information
Overview
Historical perspective
Classification
Pathophysiology
Causes
Differentiating Endometrial cancer from other Diseases
Epidemiology and Demographics
Risk factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Endometrial cancer staging On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Endometrial cancer staging All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Endometrial cancer staging
CDC on Endometrial cancer staging
Endometrial cancer staging in the news
Blogs on Endometrial cancer staging
Directions to Hospitals Treating Endometrial cancer
Risk calculators and risk factors for Endometrial cancer staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Endometrial carcinoma is surgically staged using the FIGO cancer staging system.

Stage IA: tumor is limited to the endometrium
Stage IB: invasion of less than half the myometrium
Stage IC: invasion of more than half the myometrium
Stage IIA: endocervical glandular involvement only
Stage IIB: cervical stromal invasion
Stage IIIA: tumor invades serosa or adnexa, or malignant peritoneal cytology
Stage IIIB: vaginal metastasis
Stage IIIC: metastasis to pelvic or para-aortic lymph nodes
Stage IVA: invasion of the bladder or bowel
Stage IVB: distant metastasis, including intraabdominal or inguinal lymph nodes